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Enveloped animal viruses fuse their membrane with a host cell membrane, thus delivering the virus genetic material into the cytoplasm and
initiating infection. This critical membrane fusion reaction is mediated by a virus transmembrane protein known as the fusion protein, which
inserts its hydrophobic fusion peptide into the cell membrane and refolds to drive the fusion reaction. This review describes recent advances in our
understanding of the structure and function of the class II fusion proteins of the alphaviruses and flaviviruses. Inhibition of the fusion protein
refolding reaction confirms its importance in fusion and suggests new antiviral strategies for these medically important viruses.
D 2005 Elsevier Inc. All rights reserved.
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Enveloped viruses infect cells via fusion of the virus
membrane with a host cell membrane (Earp et al., 2005;
Harrison, 2005). This critical fusion event delivers the viral
genome into the cytoplasm to initiate infection. Virus
membrane fusion can occur either at the plasma membrane
or at an intracellular location following internalization of virus
by receptor-mediated endocytosis (Smith and Helenius, 2004;
Earp et al., 2005; Sieczkarski and Whittaker, 2005). Fusion is
mediated by viral transmembrane proteins known as fusion
proteins. Upon appropriate triggering, the fusion protein0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.09.036
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E-mail address: kielian@aecom.yu.edu.interacts with the target membrane through a hydrophobic
fusion peptide and undergoes a conformational change that
drives the membrane fusion reaction. There are a variety of
fusion triggers, including various combinations of receptor
binding, receptor/coreceptor binding, and exposure to the
mildly acidic pH within the endocytic pathway (Earp et al.,
2005).
Molecular information on virus membrane fusion reactions is
important to our overall understanding of viral infection path-
ways and to efforts to generate antiviral therapies. Since virus
membranes and their fusion machines are simpler than those of
cells (Jahn et al., 2003; Sollner, 2004), virus fusion reactions
have also been important paradigms for cellular fusion reactions
and have produced both concepts and methods that have helped
to advance the overall membrane fusion field.06) 38 – 47
www.e
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fusion proteins are currently divided into two groups (Lescar
et al., 2001), the ‘‘class I’’ membrane fusion proteins
exemplified by the influenza hemagglutinin (HA) and HIV-1
gp41, and the ‘‘class II’’ proteins of the alphaviruses and
flaviviruses. The goal of this review is to summarize and
discuss our current understanding of the class II virus
membrane fusion proteins, focusing on the fusion protein
E1 of the alphavirus Semliki Forest virus (SFV) as a specific
example. The reader will be directed to relevant reviews for
summaries of work not covered in depth here due to space
constraints.
Class II fusion proteins: properties, biosynthesis, and virus
assembly
The alphaviruses and flaviviruses are members of the
Togaviridae and Flaviviridae families, respectively. These small
enveloped positive-sense RNAviruses are composed of a capsid
protein that assembles with the RNA into the nucleocapsid and
a lipid bilayer containing the viral transmembrane (TM)
proteins (Lindenbach and Rice, 2001; Schlesinger and Schle-
singer, 2001). The structures of the ectodomains of fusion
proteins from the alphaviruses and flaviviruses revealed that
although these proteins lack detectable amino acid sequence
conservation, their secondary and tertiary structures are
remarkably similar, as detailed below. Importantly, their
structures are very different from the structure of the influenza
HA, and thus, the alphavirus E1 and flavivirus E fusion proteins
were proposed as the inaugural members of the class II fusion
proteins (Lescar et al., 2001).
The alphavirus E1 protein is synthesized and folds co-
translationally with a companion or regulatory protein, termed
p62 or PE2 (Schlesinger and Schlesinger, 2001). Immediately
after insertion into the endoplasmic reticulum, the E1 and p62
proteins dimerize, an interaction that promotes the correct
folding and transport of the fusion protein to the plasma
membrane. During transport, p62 is processed by the cellular
enzyme furin, producing the mature E2 TM protein plus a
peripheral E3 protein of about 10 kDa, which does not remain
associated with the virion except in some strains of virus. The
p62/E1 dimer remains stably associated following processing to
E2. Budding occurs at the plasma membrane and produces virus
particles containing 80 trimers of E2/E1 heterodimers (Strauss et
al., 1995; Garoff et al., 2004). These particles are organized with
T = 4 icosahedral symmetry, with 240 copies of E1, E2, and
capsid protein per virion (Mancini et al., 2000; Zhang et al.,
2002).
Similarly, the flavivirus E protein is synthesized and folded
together with its regulatory prM protein, but virus budding takes
place at the endoplasmic reticulum membrane (Heinz and
Allison, 2000; Mukhopadhyay et al., 2005). The immature
flavivirus particle contains trimers of prM/E heterodimers,
similar to the alphavirus organization described above (Zhang
et al., 2003c). Furin processing of prM occurs post-budding and
produces the mature M protein, a TM protein with only ¨40
external residues. Following processing, the virus surfacereorganizes dramatically to give 90 E–E homodimers arranged
with T = 3 icosahedral symmetry in a ‘‘herringbone’’ pattern
(Kuhn et al., 2002; Mukhopadhyay et al., 2003; Zhang et al.,
2003a; Mukhopadhyay et al., 2005).
Pre-fusion structure of class II fusion proteins
Soluble ectodomains were generated by proteolytic cleavage
of the SFV E1 protein, crystallized, and used to solve the
structure (Wengler et al., 1999; Lescar et al., 2001). Similar E
protein ectodomains were generated by proteolysis of the
flavivirus tick-borne encephalitis virus (TBE) or by expression
of the E protein ectodomain from dengue virus (DV) 2 or 3, and
were used to determine the structures of these proteins (Rey et
al., 1995; Modis et al., 2003; Zhang et al., 2004; Modis et al.,
2005). As exemplified by the structure of SFV E1 (Fig. 1A), the
class II fusion proteins are elongated finger-like molecules with
three globular domains composed almost entirely of ß-sheets.
Domain I is a ß-barrel that contains the N-terminus and two
long insertions that connect adjacent ß-strands and together
form the elongated domain II. The first of these insertions
contains the highly conserved fusion peptide loop at its tip,
connecting the c and d ß-strands of domain II (termed the cd
loop) and containing 4 conserved disulfide bonds including
several that are located at the base of the fusion loop. The
second insertion contains the ij loop at its tip, adjacent to the
fusion loop, and one conserved disulfide bond at its base. A
hinge region is located between domains I and II. This flexible
region allows different angles between the two domains in the
immature vs. mature, furin-processed DV E protein and also
between the pre- and post-fusion conformations of both E and
E1 (reviewed in Mukhopadhyay et al., 2005). On the other side
of domain I, a short linker region connects domain I to domain
III, a ß-barrel with an immunoglobulin-like fold stabilized by
three conserved disulfide bonds. In the full-length molecule,
domain III is followed by a stem region that connects the
protein to the virus TM anchor. Fitting of the structure of
alphavirus E1 to cryo-electron microscopy reconstructions of
the virus particle reveals that E1 is located almost parallel to the
virus membrane, and that E1–E1 interactions form the
icosahedral lattice (Lescar et al., 2001; Pletnev et al., 2001;
Zhang et al., 2002).
The class II proteins to date include the flavivirus E and
alphavirus E1 proteins. While structural information is not yet
available, it seems very likely that members of other genera in
the Flaviviridae family (e.g., the hepacivirus hepatitis C virus
(HCV) or pestiviruses such as classical swine fever virus) or in
the Togaviridae family (the rubivirus rubella virus) also contain
class II fusion proteins. Similar to alpha- and flaviviruses, these
viruses have two glycoproteins encoded in tandem, suggesting a
similar arrangement of a regulatory protein located N-terminal
to the membrane fusion protein. Modeling studies of the
structures of the more C-terminally located glycoproteins of
HCV (Yagnik et al., 2000) and classical swine fever virus
(Garry and Dash, 2003) suggest that these proteins may indeed
be class II membrane fusion proteins, although an alternative
model suggests that the more N-terminal HCV glycoprotein is
Fig. 1. Pre-fusion and post-fusion structures of the Semliki Forest virus E1 protein. (A) The pre-fusion structure of the monomeric SFV E1 ectodomain (Lescar et al.,
2001) is shown at the top of the panel, with domains I and III indicated in red and blue, respectively. Domain II is depicted in orange and yellow to indicate the two
extensions from domain I. The fusion peptide loop is shown in green (fp), the linker between dI and dIII is in purple, and the positions of the ij loop and the hinge
region are indicated. A cartoon of the ectodomain is shown below the structure, with domains I, II, and III colored respectively in red, yellow, and blue, and the
fusion loop indicated by the green star. The bottom of the panel shows a linear diagram of the E1 sequence color-coded to match the structure above and labeled to
indicate the boundary of each region in the SFV sequence. The stem region is shown in grey, the TM domain in black, and the cytoplasmic tail of E1 (residues 437–
438) depicted in white. These regions are not present in the ectodomain structure. (B) The post-fusion structure of the SFV E1 ectodomain. One E1* subunit from the
homotrimer is shown on the left, colored as in Fig. 1. The E1* homotrimer is shown in the middle with one E1* subunit colored as in Fig. 1 and the other two E1*
subunits shown in light grey. Domain III (blue) and the stem (shown in dark grey) extend along the core trimer towards the fusion loops (green). The cartoon in the
right is used to illustrate the hairpin conformation and depicts the full-length membrane-inserted E1 homotrimer with the complete stem (grey), TM domain (black),
and fused membrane (light purple).
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Bunyaviridae family, the C-terminal glycoprotein Gc of the
orthobunyavirus La Crosse virus was shown to be the principal
determinant of virus membrane fusion (Plassmeyer et al., 2005),
while modeling studies predict that the Gc proteins from La
Crosse virus and from several other genera in the Bunyaviridae
are class II fusion proteins (Garry and Garry, 2004; Plassmeyer
et al., 2005). For many virus families, there is not yet sufficient
information to identify and classify the membrane fusion
proteins. Future functional and structural studies will enablemore definitive assignment of viral proteins to class II and
comparison of their properties.
Class I fusion proteins
In contrast to the pre-fusion structures of the class II
proteins, the class I fusion proteins are homotrimers that project
vertically from the virus membrane and contain mostly a-
helical structure (Skehel and Wiley, 2000; Harrison, 2005). An
important feature of the class I fusion proteins is that they are
M. Kielian / Virology 344 (2006) 38–47 41trimers both before and after the fusion reaction. During fusion,
they insert into the target membrane and refold to form a stable
rod-like molecule with the fusion peptides and transmembrane
domains at the same side, a structure termed a ‘‘trimer of
hairpins’’ (Eckert and Kim, 2001). The hairpin is formed by
interactions between an N-terminal trimeric a-helical coiled-
coil inner layer connecting to the fusion peptide and an outer
C-terminal layer connecting to the TM domain, thus position-
ing the two membrane-inserted domains at the same side of the
refolded molecule. Transition to this hairpin structure is
believed to drive the fusion reaction (Melikyan et al., 2000;
Russell et al., 2001), and fusion and virus infection can be
blocked by addition of peptides that mimic the N- or C-
terminal interacting regions (Wild et al., 1993; Eckert and Kim,
2001; Moore and Doms, 2003; Harrison, 2005).
Virus entry and the conformational changes in class II
proteins during virus membrane fusion
Both alphaviruses and flaviviruses infect cells by receptor-
mediated endocytic uptake and a low pH-triggered membrane
fusion reaction (Helenius et al., 1980; Heinz and Allison,
2000). The uptake pathway has been particularly well studied
for SFV, which infects by internalization into an endosome
compartment dependent on the cellular proteins dynamin,
Eps15, and Rab5 (DeTulleo and Kirchhausen, 1998; Siecz-
karski and Whittaker, 2002, 2003; Earp et al., 2003). Fusion in
the endosome and subsequent virus infection are specifically
blocked by inhibitors of endosomal acidification such as
bafilomycin or NH4Cl (Helenius et al., 1982; Glomb-Rein-
mund and Kielian, 1998a; Earp et al., 2003). Typical SFV
strains fuse with a threshold of ¨pH 6.2 either in the cell or
with pure lipid liposomes in vitro (White and Helenius, 1980;
White et al., 1980; Kielian et al., 1986). Fusion of SFV and the
alphavirus Sindbis virus is cholesterol-dependent and shows a
specific requirement for the sterol 3ß-hydroxyl group (White
and Helenius, 1980; Phalen and Kielian, 1991; Bron et al.,
1993; Lu et al., 1999; Smit et al., 1999). This cholesterol
requirement does not appear to be due to bulk physical effects
of cholesterol on the membrane such as changes in membrane
fluidity or formation of microdomains, since cholesterol
analogues such as androstanol or coprostanol can support
membrane fusion without producing these membrane effects
(Kielian and Helenius, 1984; Kielian et al., 2000; Waarts et al.,
2002). SFV and Sindbis fusion is also promoted by the
presence of low concentrations of sphingolipid in the target
membrane (Nieva et al., 1994; Wilschut et al., 1995; Samsonov
et al., 2002; Waarts et al., 2002). The fusion reactions of the
flaviviruses TBE and West Nile virus are also enhanced by
cholesterol, but the requirement appears less stringent (Gollins
and Porterfield, 1986; Corver et al., 2000; Stiasny et al., 2003),
and no sphingolipid requirement has been observed for fusion
of these viruses (Corver et al., 2000; Stiasny et al., 2003).
Biochemical studies of SFV have defined a series of
conformational changes that occur during the low pH-induced
virus membrane fusion reaction (reviewed more extensively
in Garoff et al., 1994; Kielian, 1995; Kielian et al., 2000).Immediately after exposure of SFV to low pH, the stable E2–E1
dimer interaction is disrupted, releasing monomeric E1. Dimer
dissociation results in the exposure of the E1 fusion loop, which
then inserts into the target membrane in a low pH and
cholesterol-dependent interaction. E1-membrane insertion thus
resembles the low pH- and cholesterol-dependent SFV mem-
brane fusion reaction. E1 then forms a homotrimer as
demonstrated by cross-linking, sucrose gradient sedimentation,
relative resistance to trypsin digestion, and migration as a trimer
on SDS-PAGE following solubilization in SDS-sample buffer at
30 -C (Wahlberg et al., 1992; Wahlberg and Garoff, 1992). The
E1 trimer is required for fusion (Kielian et al., 1996), and the
kinetics and pH dependence of trimer formation closely correlate
with those of membrane fusion (Bron et al., 1993; Glomb-
Reinmund and Kielian, 1998b; Smit et al., 2001). The low pH-
induced E1 conformational change also results in the exposure
of a monoclonal antibody epitope that has been mapped to
domain I (Ahn et al., 1999). The same pattern of conformational
changes could also be induced by treatment of the SFV E1
ectodomain, E1*, at low pH in the presence of cholesterol-
containing liposomes (Klimjack et al., 1994). Under these
conditions, the soluble monomeric E1* protein inserts into target
membranes via the fusion loop, exposes the acid-specific
xepitope, and forms a trypsin- and SDS-resistant homotrimer
that is oriented perpendicular to the target membrane (Klimjack
et al., 1994; Gibbons et al., 2003). Interestingly, E1* membrane
insertion is highly cooperative and leads to the formation of a
lattice composed of rings of 5 and 6 trimers on the surface of the
liposomes (Gibbons et al., 2003). Similar cooperative membrane
interactions were observed for the TBE and DV fusion proteins
(Modis et al., 2004; Stiasny et al., 2004).
Structure of the class II low pH-induced homotrimer
A key question for the class II virus fusion proteins was the
extent to which their fusion mechanism resembled that of the
class I fusion proteins. The class II fusion proteins convert
during fusion from dimers to homotrimers but were not
predicted to form a coiled-coil based structure. To characterize
the low pH-induced refolding of the SFV fusion protein, the
membrane-inserted ectodomain homotrimer was solubilized,
purified, crystallized, and the three-dimensional structure
determined (Gibbons et al., 2004b, 2004c).
The homotrimer is composed of a central ‘‘core trimer’’
made up of domains I and II, with the three fusion loops at
the tip of the trimer (Fig. 1B). A rotation of about 15- has
occurred about the domain I and II hinge regions. Domain III
folds back against the core trimer, moving about 37 A˚
towards the tip of E1 and fitting into the groove formed by
two adjacent E1 molecules. About half of the stem region is
present in E1*, and while this portion of the protein was
disordered in the E1* monomer, it is highly ordered in the
E1* homotrimer and interacts along the length of the core
trimer. The missing portion of the stem is sufficiently long to
span the remaining trimer length and connect to the TM
domain (see schematic in Fig. 1B). Thus, although based on a
very different structure from the class I proteins, SFV E1
M. Kielian / Virology 344 (2006) 38–4742forms an analogous hairpin with the fusion loops and the TM
domains at the same end of a rod-like trimer. The structures
of the fusion protein trimers from DV2 and TBE are
strikingly similar to that of the SFV HT, including the core
trimer interactions, hinge rotation, and dramatic fold-back of
domain III (Bressanelli et al., 2004; Modis et al., 2004). The
structure of the class II trimeric hairpin strongly supports the
idea that the class I and class II proteins mediate fusion by a
similar mechanism.
Functional features of class II proteins
Structural and functional studies thus indicate that during
fusion, the class II fusion protein reorients vertically, inserts
into the target membrane, trimerizes and folds to produce the
final hairpin (Fig. 2). The first step in this fusion cascade is the
disruption of the alphavirus E2–E1 dimer interaction (or
flavivirus E–E dimer interaction), freeing the fusion protein
monomer for subsequent low pH-dependent conformational
changes. For both alphaviruses and flaviviruses, furin proces-
sing of the companion protein is an important regulatory step
without which the virus is resistant to fusion and has decreased
infectivity (Salminen et al., 1992; Stadler et al., 1997; Zhang et
al., 2003b). In the case of the alphaviruses, fusion of the
unprocessed virus can still take place but requires treatment at
¨pH 5.0 or below, rather than the normal wild-type SFV fusion
threshold of ¨pH 6.2 (Salminen et al., 1992; Smit et al., 2001;
Zhang et al., 2003b). This shift in the pH threshold of fusion is
due to a shift in the pH threshold for dissociation of the
unprocessed vs. processed heterodimer. Processing of the
alphavirus p62 protein does not appear to affect the fusion
protein other than by changing the nature of the dimer
interaction. This contrasts with the class I proteins in which
processing of the fusion protein itself is typically required to
make the protein fusion-competent (Skehel and Wiley, 2000;
Earp et al., 2005; Harrison, 2005).Fig. 2. Model for the SFV membrane fusion reaction. (A) Diagram of a portion of the
with E1, and virus lipid bilayer (light brown), shown adjacent to target membrane
loop (green star). (C) Low pH and cholesterol trigger the insertion of the fusion loop
fold-back towards the fusion loop. Trimers interact cooperatively to distort the targ
shown). (E) Post-fusion conformation: the target and virus membranes have complet
membrane leaflets, and the opening of a fusion pore. E1 is in its final, completelyFollowing dissociation of the class II dimer, the fusion loops
insert into the target membrane. The structures of the class II
homotrimer predict that the fusion loops insert only peripherally
into the bilayer, projecting their aromatic side chains into the
aliphatic region of the outer leaflet of the target membrane
(Bressanelli et al., 2004; Gibbons et al., 2004c; Modis et al.,
2004). This membrane insertion step appears to be the major
point in the alphavirus fusion pathway that is cholesterol-
dependent, and it promotes trimerization of E1 (Kielian and
Helenius, 1984; Klimjack et al., 1994; Ahn et al., 2002).
Insertion of the TBE ectodomain is also promoted by cholesterol,
and similar to the SFV E1 protein, this requirement involves the
sterol 3ß-hydroxyl group (Stiasny et al., 2002, 2003).
The role of cholesterol in alphavirus entry and fusion has
been addressed using cholesterol-depleted insect cells. These
cells are reduced by ¨3 logs in their ability to be infected by
SFV or Sindbis virus, while infection by the cholesterol-
independent rhabodovirus vesicular stomatitis virus is unaf-
fected (Phalen and Kielian, 1991; Lu et al., 1999). SFV
mutants were isolated by selection for growth in cholesterol-
depleted cells. These studies identify single amino acid changes
in the ij loop and in the hinge region of domain II which confer
decreased dependence on cholesterol (Vashishtha et al., 1998;
Chatterjee et al., 2000, 2002).
The ij loop, the site of the most frequently selected mutation
affecting cholesterol dependence, lies adjacent to the fusion loop
at the tip of domain II (Fig. 1). All of the reported alphavirus and
flavivirus sequences contain a histidine residue in the ij loop,
located at position 230 in the SFV E1 sequence (Chanel-Vos and
Kielian, 2004). Substitution of E1 H230 with alanine in the SFV
infectious clone produced a virus mutant that is non-infectious
and shows no detectable membrane fusion activity, even in the
initial steps of lipid mixing (Chanel-Vos and Kielian, 2004).
Interestingly, the H230Amutant appears to have normal low pH-
induced conformational changes including dimer dissociation,
fusion loop exposure, cholesterol-dependent target membranepre-fusion virus surface, with E1 colored as in Fig. 1, E2 (grey) shown in dimer
(blue). (B) Low pH dissociates the E2–E1 heterodimer and exposes the fusion
, promoting E1 trimerization. (D) E1 refolding: domain III and the stem region
et and virus membranes (only two trimers of the proposed ring of trimers are
ely fused through mixing of the outer membrane leaflets (hemifusion), the inner
folded hairpin conformation in the fused (purple) membrane.
M. Kielian / Virology 344 (2006) 38–47 43association, and E1 homotrimer formation. These results suggest
the existence of a novel late intermediate in the fusion pathway,
perhaps involving the interaction of the ij loop with the target
membrane or the stem region.
The structural studies of the SFV E1* homotrimer identified
cooperative interactions between trimers mediated through the
fusion loops and through the domain III regions, generating
rings of 5 and 6 homotrimers (Gibbons et al., 2003, 2004c).
These observations suggest that E1 carries out fusion by the
concerted action of homotrimers acting in an assembly at the
fusion site. Models of such interactions suggest that they would
induce membrane curvature and produce a ‘‘lipid stalk’’ fusion
intermediate (Gibbons et al., 2004c). This agrees with recent
studies indicating that, similar to the class I fusion proteins,
SFV fusion occurs through a transient hemifusion stage
involving mixing of the outer leaflets of the virus and target
membranes (Zaitseva et al., 2005). While more work is needed
on the functional significance of inter-trimer interactions in
class II fusion, the strongly cooperative nature of fusion
protein–membrane insertion, and the observed trimer associa-
tions suggest that such interactions are likely to play an
important role in the fusion mechanism.
Inhibition of class II fusion proteins
The available structural and functional information on the
class II fusion reaction suggests several possible approaches to
inhibition of fusion and infection. The hinge is clearly a
flexible region that undergoes changes during virus maturation
and during conversion from the neutral pH conformation to the
low pH-induced trimer (Gibbons et al., 2004c; Mukhopadhyay
et al., 2005). Functional evidence points to an important role of
the hinge region in fusion. For example, in flaviviruses, the
hinge region is the site of a number of mutations that affect the
pH dependence of fusion (Rey et al., 1995), while in
alphaviruses, two of the three known mutations that reduce
cholesterol dependence lie within the hinge region (Chatterjee
et al., 2002). A hydrophobic pocket is located within the hinge
region, and the crystal structure of the neutral pH dengue E
monomer contains a molecule of n-octyl-ß-glucoside in this
pocket (Modis et al., 2003). Blocking this pocket or otherwise
impairing hinge flexibility could act to disrupt the class II
fusion reaction.
It is clear from the structure of the SFV E1* homotrimer
that the existing stem region interacts along the length of the
core trimer (Gibbons et al., 2004c). Although the stem region
is not present in the crystallized flavivirus trimers, analogous
stem interactions are predicted in the case of these molecules
(Bressanelli et al., 2004; Modis et al., 2004). The stem
peptides and their interaction sites along the core trimer are
potential targets for inhibition. The presence of a DV stem-
derived peptide blocks infection by the flaviviruses DV and
West Nile virus (Hrobowski et al., 2005). It will be
interesting to determine the mechanism of action of this
and other peptides and their effects on virus fusion.
Additional potential targets include the sites of monomer–
monomer interaction within the core trimer, and the linkerregion between domains I and III, which becomes signifi-
cantly more extended during trimerization.
A dramatic feature of the refolding of the class II fusion
proteins is the movement of domain III towards the fusion
loop. This aspect of the class II refolding reaction was recently
assessed as a target for the inhibition of membrane fusion (Liao
and Kielian, 2005). Recombinant SFV and DV domain III
proteins were produced with or without the stem region. These
domain III proteins inhibit virus fusion and infection when
present during low pH-induced fusion of virus with the plasma
membrane and also when present during virus endocytic
uptake. Inhibition shows cross-reactivity among members of
the same virus genus (e.g., SFV domain III against Sindbis
virus, DV2 domain III against DV1) but not between genera
(e.g., SFV domain III against DV, DV domain III against SFV).
This suggests the presence of key interaction sites that are
conserved between the viruses that show cross-inhibition, in
agreement with the known pattern of sequence conservation in
the domain III–core trimer interface. Exogenous domain III
proteins block both complete fusion and lipid mixing but do
not affect virus-receptor binding. Immunoprecipitation studies
using radiolabeled SFV showed that domain III proteins bind
stably to a trimeric E1 intermediate generated during the low
pH-induced conformational change, the first identification of
this class II fusion intermediate. Both the fusion inhibition and
E1 binding of domain III are enhanced by the presence of the
stem region, suggesting that the stem increases the stability of
the domain III–core trimer interaction. Binding of exogenous
domain III alters the conformation of the E1 homotrimer,
making it less resistant to SDS dissociation and less reactive
with the acid conformation-specific monoclonal antibody.
Taken together, these data indicate that exogenous domain III
binds to a relatively long-lived trimeric intermediate of E1 prior
to formation of the final hairpin, and that binding blocks fusion
by preventing fold-back of the endogenous domain III (Fig. 3).
This is the first demonstration of dominant-negative inhibition
of class II membrane fusion and clearly shows that domain III
plus stem, rather than stem alone, is the functional analogue of
the C-terminal interacting region of the class I proteins. The
results suggest that the interaction of domain III with the core
trimer can serve as a new target for the development of antiviral
reagents against class II viruses.
Future directions
Our current knowledge of the structure and function of the
alphavirus and flavivirus fusion proteins suggests models for
the class II fusion reaction (Fig. 2) and points of intervention
for its inhibition (Fig. 3). Much remains to be done to define
the molecular mechanism of class II fusion and to answer the
important new questions raised by the recent data. Some of
these questions are presented here, and more will doubtless be
identified as work on class II proteins progresses.
In spite of the structural information for the monomer and
trimer, important issues about the conformational changes in
class II fusion proteins remain. We know that following
dissociation of the E2–E1 dimer SFV E1 responds indepen-
Fig. 3. Model for the mechanism of inhibition of class II membrane fusion by exogenous domain III. Panel C illustrates step (C) of the fusion model from Fig. 2,
showing a membrane-inserted trimeric form of E1. This is proposed as the relatively long-lived trimeric intermediate that is the target for binding of exogenous
domain III. In the absence of exogenous domain III, fusion proceeds to the final step (E), through the stages discussed in Fig. 2. Panel CV/C illustrates the interaction
of exogenous domain III (turquoise ball) with the trimer intermediate of panel C. Binding of exogenous domain III produces a mixed population of trimers blocked at
various stages of the fold-back reaction (indicated by CV, C, and the dotted line connecting them), resulting in inhibition of the fusion reaction. This figure was
redrawn from Liao and Kielian (2005) and used by copyright permission of The Rockefeller University Press.
M. Kielian / Virology 344 (2006) 38–4744dently to low pH, but the mechanism of this E1 pH effect is
unclear. E1 contains a number of conserved histidine residues,
and it is possible that some of these are involved, although
interestingly the H230A mutant does not show detectable
alteration in pH dependence (Chanel-Vos and Kielian, 2004).
Part of E1’s response to low pH involves its insertion into the
target membrane. The data suggest that insertion is not due to
simple exposure of the fusion peptide, but rather, that it reflects
low pH- and cholesterol-dependent effects on E1 (Gibbons et
al., 2004a). Although it is clear that the membrane interaction
of both the E1 ectodomain and the SFV particle are dependent
on low pH and cholesterol, how cholesterol acts to promote
membrane insertion and E1 conformational changes is not
known. While there is a model for the interaction of the fusion
loop with the target membrane, the role of fusion loop residues
in membrane interaction, the depth of membrane insertion, and
the modulation of insertion and cholesterol dependence by the
hinge region and ij loop are unclear. The ectodomain structures
lack the TM domain, and we have little information on the role
of the TM domain in fusion or its possible interactions with the
membrane-inserted fusion loop. It will also be interesting to
compare the membrane insertion reactions of alphaviruses and
flaviviruses, since their fusion loops differ in length and their
fusion reactions differ in cholesterol requirement.For the conformational changes in class II fusion proteins that
have already been defined, it will now be important to order
these steps and correlate them with the steps in membrane
fusion. We also need a more complete picture of how the virus
particle reorganizes during fusion. For example, the structure of
alphavirus E2 and its rearrangements during fusion are
essentially undefined. Even for flaviviruses where the E–E
dimer structure and its organization on the virus particle have
been highly characterized, the rearrangement of the particle
during fusion is unclear. A better understanding of the virus
particle in fusion must also include consideration of fusion
protein cooperativity and the possibility of differential roles for
the observed pentameric and hexameric trimer assemblies.
Given the medical relevance of many of the class II viruses,
inhibitors are important both for their analysis and for the
development of antiviral drugs. Further studies will determine
the most useful targets among the stem, hinge, domain III and
other sites discussed above, and the feasibility of inhibiting
these targets by small molecules. It will be important to define
the role of these regions in virion assembly interactions vs.
their roles in virus fusion. Once fusion protein inhibition is
established for a specific target, it will also be important to
determine if this approach can be generally applicable for other
members of class II.
M. Kielian / Virology 344 (2006) 38–47 45Lastly, an important objective will be the definitive identi-
fication of other class II viruses and the characterization of the
common and distinct features of the members of class II. The
class I virus fusion reaction shares common structural features
with the cellular SNARE proteins involved in intracellular
fusion reactions (Skehel and Wiley, 1998; Sollner, 2004). Are
there cellular homologues of the class II fusion proteins, and are
they involved in intracellular or extracellular fusion events?
Many of these ideas are currently rough and exploratory in
nature but give a sense of the important questions that will make
the class II fusion field exciting in the years ahead.
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